"March 5, 2013 -- Spring allergy season is again off to an early start in many parts of the country, and doctors say there are some signs it may be even more miserable than usual this year.
Last year was the fourth warmest winter on re"...
- Patient Information:
Details with Side Effects
DOSAGE AND ADMINISTRATION
Adults and children 6 years of age and over: The recommended dose of CLARITIN (loratadine) is one 10 mg tablet or reditab, or 2 teaspoonfuls (10 mg) of syrup once daily.
Children 2 to 5 years of age: The recommended dose of CLARITIN (loratadine) Syrup is 5 mg (1 teaspoonful) once daily.
In adults and children 6 years of age and over with liver failure or renal insufficiency (GFR < 30 mL/min), the starting dose should be 10 mg (one tablet or two teaspoonfuls) every other day. In children 2 to 5 years of age with liver failure or renal insufficiency, the starting dose should be 5 mg (one teaspoonful) every other day.
Administration of CLARITIN REDITABS (loratadine rapidly-disintegrating tablets): Place CLARITIN REDITABS (loratadine rapidly-disintegrating tablets) on the tongue. Tablet disintegration occurs rapidly. Administer with or without water.
CLARITIN (loratadine) Tablets: 10 mg, white to off-white compressed tablets; impressed with the product identification number “458” on one side and “CLARITIN (loratadine) 10” on the other; high-density polyethylene plastic bottles of 100 (NDC 0085-0458-03) and 500 (NDC 0085-0458-06). Also available, CLARITIN (loratadine) Unit-of-Use packages of 30 tablets (10 tablets per blister card) (NDC 0085-0458-05); and 10 x 10 tablet Unit Dose-Hospital Pack (NDC 0085-0458-04).
Protect Unit-of-Use packaging and Unit Dose-Hospital Pack from excessive moisture.
Store between 2° and 30°C (36° and 86°F).
CLARITIN (loratadine) Syrup: Clear, colorless to light-yellow liquid, containing 1 mg loratadine per mL; amber glass bottles of 16 fluid ounces (NDC 0085-1223-01).
Store between 2° and 25°C (36° and 77°F).
CLARITIN REDITABS (loratadine rapidly-disintegrating tablets): CLARITIN REDITABS (loratadine rapidly-disintegrating tablets), 10 mg, white to off-white blister-formed tablet; impressed with the letter “C” on one side; Unit-of-Use polyvinyl chloride blister packages of 30 tablets (three laminated foil pouches, each containing one blister card of 10 tablets) supplied with Patient's Instructions for Use (NDC 0085-1128-02).
Keep CLARITIN REDITABS (loratadine rapidly-disintegrating tablets) in a dry place.
Store between 2° and 25°C (36° and 77°F). Use within 6 months of opening laminated foil pouch, and immediately upon opening individual tablet blister.
Schering Corporation Kenilworth, NJ 07033, USA. Rev. 9/00. FDA rev date:
Last reviewed on RxList: 11/6/2007
This monograph has been modified to include the generic and brand name in many instances.
Additional Claritin Information
Claritin - User Reviews
Claritin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.